Literature DB >> 21317392

Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.

Kathryn Trandem1, Jingxian Zhao, Erica Fleming, Stanley Perlman.   

Abstract

Acute viral encephalitis requires rapid pathogen elimination without significant bystander tissue damage. In this article, we show that IL-10, a potent anti-inflammatory cytokine, is produced transiently at the peak of infection by CD8 T cells in the brains of coronavirus-infected mice. IL-10(+)CD8 and IL-10(-)CD8 T cells interconvert during acute disease, possibly based on recent Ag exposure. Strikingly, IL-10(+)CD8 T cells were more highly activated and cytolytic than IL-10(-)CD8 T cells, expressing greater levels of proinflammatory cytokines and chemokines, as well as cytotoxic proteins. Even though these cells are highly proinflammatory, IL-10 expressed by these cells was functional. Furthermore, IL-10 produced by CD8 T cells diminished disease severity in mice with coronavirus-induced acute encephalitis, suggesting a self-regulatory mechanism that minimizes immunopathological changes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317392      PMCID: PMC3063297          DOI: 10.4049/jimmunol.1003292

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

2.  IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment.

Authors:  Ellen M Palmer; Beth C Holbrook; Subhashini Arimilli; Griffith D Parks; Martha A Alexander-Miller
Journal:  Virology       Date:  2010-09-01       Impact factor: 3.616

3.  Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

Authors:  A D Santin; P L Hermonat; A Ravaggi; S Bellone; S Pecorelli; J J Roman; G P Parham; M J Cannon
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus.

Authors:  Kathryn Trandem; Daniela Anghelina; Jingxian Zhao; Stanley Perlman
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

5.  CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination.

Authors:  G F Wu; A A Dandekar; L Pewe; S Perlman
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 6.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

7.  De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system.

Authors:  Jingxian Zhao; Jincun Zhao; Stanley Perlman
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

8.  The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.

Authors:  Lionel Apetoh; Francisco J Quintana; Caroline Pot; Nicole Joller; Sheng Xiao; Deepak Kumar; Evan J Burns; David H Sherr; Howard L Weiner; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2010-08-01       Impact factor: 25.606

9.  New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Authors:  Elise Landais; Pablo A Romagnoli; Adam L Corper; John Shires; John D Altman; Ian A Wilson; K Christopher Garcia; Luc Teyton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.

Authors:  Margarida Saraiva; Jillian R Christensen; Marc Veldhoen; Theresa L Murphy; Kenneth M Murphy; Anne O'Garra
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more
  83 in total

1.  ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Authors:  Nicholas A Zumwalde; Eisuke Domae; Matthew F Mescher; Yoji Shimizu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Rachy Abraham; Ashley Nelson; Diane E Griffin
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Interleukin 10 promotes immune response by increasing the survival of activated CD8+ T cells in human papillomavirus 16-infected cervical cancer.

Authors:  Li Li; Yan Ma; Shuang Liu; Jin Zhang; Xin-Yan Xu
Journal:  Tumour Biol       Date:  2016-10-11

4.  Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways.

Authors:  Maria Abildgaard Steffensen; Christina Fenger; Jeanette Erbo Christensen; Carina Krogsgaard Jørgensen; Maria Rosaria Bassi; Jan Pravsgaard Christensen; Bente Finsen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

5.  Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity.

Authors:  Weiyi Peng; Jodi A McKenzie; Patrick Hwu
Journal:  Cancer Discov       Date:  2016-09       Impact factor: 39.397

6.  Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression.

Authors:  Filiberto Cedeno-Laurent; Matthew Opperman; Steven R Barthel; Vijay K Kuchroo; Charles J Dimitroff
Journal:  J Immunol       Date:  2012-02-17       Impact factor: 5.422

7.  CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.

Authors:  Timothy W Phares; Stephen A Stohlman; Mihyun Hwang; Booki Min; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

8.  IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma.

Authors:  Lixin Wang; Jin-Qing Liu; Fatemeh Talebian; Zhenzhen Liu; Li Yu; Xue-Feng Bai
Journal:  Oncoimmunology       Date:  2015-05-13       Impact factor: 8.110

9.  IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.

Authors:  Zhenzhen Liu; Jin-Qing Liu; Fatemeh Talebian; Lai-Chu Wu; Shulin Li; Xue-Feng Bai
Journal:  Eur J Immunol       Date:  2013-01-15       Impact factor: 5.532

10.  CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.

Authors:  Katherine A Murphy; Jami R Erickson; Charles S Johnson; Charles E Seiler; Jessica Bedi; Peisheng Hu; G Elizabeth Pluhar; Alan L Epstein; John R Ohlfest
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.